T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment

Crespo, Joel, Sun, Haoyu, Welling, Theodore H, Tian, Zhigang, Zou, Weiping·2013·Current Opinion in Immunology

Cited by (750)

Items 201–300 of 750

  1. Bladder cancer cells induce immunosuppression of T cells by supporting PD‐L1 expression in tumour macrophages partially through interleukin 10
    Xingyuan Wang, Shaobin Ni, Qi-Yin Chen, Li Ma, Zhi-xing Jiao, Chunyang Wang, Guang Jia · 2016 · Cell Biology International
  2. Factors affecting tumor responders and predictive biomarkers of toxicities in cancer patients treated with immune checkpoint inhibitors
    Liqin Yao, Gang Jia, Lingeng Lu, Ying Bao, Wenxue Ma · 2020 · International Immunopharmacology
  3. Breaking Bottlenecks for the TCR Therapy of Cancer
    Gaissmaier, Lena, Elshiaty, Mariam, Christopoulos, Petros · 2020 · Cells
  4. Immune escape and metastasis mechanisms in melanoma: breaking down the dichotomy
    Carl A. Shirley, Gagan Chhabra, Deeba Amiri, Hao Chang, Nihal Ahmad · 2024 · Frontiers in Immunology
  5. 1α,25(OH) 2 D 3 reverses exhaustion and enhances antitumor immunity of human cytotoxic T cells
    Peng Li, Xinhai Zhu, Guangchao Cao, Ruan Wu, Ke Li, Wenhui Yuan, Biyun Chen, Guodong Sun, Xichun Xia, Hua Zhang et al. · 2021 · Journal for ImmunoTherapy of Cancer
  6. Inflammation and cancer: molecular mechanisms and clinical consequences
    Hikmet Akkız, Halis Şimşek, Deniz Balcı, Yakup Ülger, Engin Onan, Nevin Akcaer Ozturk, Anıl Delik · 2025 · Frontiers in Oncology
  7. Overview of Current Immunotherapeutic Strategies for Glioma
    Anda‐Alexandra Calinescu, Neha Kamran, Gregory J. Baker, Yohei Mineharu, Pedro Ricardo Lowenstein, Maria Graciela Castro · 2015 · Immunotherapy
  8. Integrative analysis of imaging and transcriptomic data of the immune landscape associated with tumor metabolism in lung adenocarcinoma: Clinical and prognostic implications
    Hongyoon Choi, Kwon Joong Na · 2018 · Theranostics
  9. Immunology‐Guided Biomaterial Design for Mucosal Cancer Vaccines
    Shiran Ferber, Rodrigo J. Gonzalez, Alexander M. Cryer, Ulrich H. von Andrian, Natalie Artzi · 2019 · Advanced Materials
  10. Immune Tolerance Regulation Is Critical to Immune Homeostasis
    Lei Han, Tianxiang Wu, Qin Zhang, Anning Qi, Xiaohui Zhou · 2025 · Journal of Immunology Research
  11. Coley’s Lessons Remembered
    Maurice Orange, Uwe Reuter, Uwe Hobohm · 2016 · Integrative Cancer Therapies
  12. Resident T Cells Are Unable To Control Herpes Simplex Virus-1 Activity in the Brain Ependymal Region during Latency
    Chandra M. Menendez, Jeremy K. Jinkins, Daniel J.J. Carr · 2016 · The Journal of Immunology
  13. PD-1 /PD-L1 checkpoint in hematological malignancies
    Ombretta Annibali, Anna Crescenzi, Valeria Tomarchio, Anastasia Pagano, Antonella Bianchi, Alba Grifoni, Giuseppe Avvisati · 2018 · Leukemia Research
  14. Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response
    Roger Gilabert‐Oriol, Gemma M. Ryan, Ada W.Y. Leung, Natalie S. Firmino, Kevin L. Bennewith, Marcel B. Bally · 2018 · International Journal of Molecular Sciences
  15. Response kinetics reveal novel features of ageing in murine T cells
    Daan K. J. Pieren, Noortje A. M. Smits, Martijn D. B. van de Garde, Teun Guichelaar · 2019 · Scientific Reports
  16. Senescence in Pulmonary Fibrosis: Between Aging and Exposure
    Alessandro Venosa · 2020 · Frontiers in Medicine
  17. Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer
    Katharina Auer, Anna Bachmayr-Heyda, Nyamdelger Sukhbaatar, Stefanie Aust, Klaus G. Schmetterer, Samuel M. Meier, Christopher Gerner, Christoph Grimm, Reinhard Horvat, Dietmar Pils · 2016 · Oncotarget
  18. KLRG1 restricts memory T cell antitumor immunity
    Lei Li, Shanshan Wan, Kaixiong Tao, Guobin Wang, Ende Zhao · 2016 · Oncotarget
  19. High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome
    Peter Hollander, Peter Kamper, Karin Ekstrom Ekstroem Smedby, Gunilla Enblad, Maja Ludvigsen, Julie Bondgaard Mortensen, Rose‐Marie Amini, Stephen Jacques Hamilton-Dutoit, Francesco d’Amore, Daniel Molin et al. · 2017 · Blood Advances
  20. Phenotypic and functional analysis of malignant mesothelioma tumor-infiltrating lymphocytes
    Astero Klampatsa, Shaun O’Brien, Jeffrey C. Thompson, Abhishek S. Rao, Jason E. Stadanlick, Marina C. Martinez, Maria Liousia, Edward Cantu, Keith A. Cengel, Edmund K. Moon et al. · 2019 · OncoImmunology
  21. Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy
    Anne M. Macpherson, Simon Charles Barry, Carmela Ricciardelli, Martin Klaus Oehler · 2020 · Journal of Clinical Medicine
  22. Dynamic changes in circulating PD-1+CD8+ T lymphocytes for predicting treatment response to PD-1 blockade in patients with non-small-cell lung cancer
    Chang Gon Kim, Min Hee Hong, Kyung Hwan Kim, In‐Ho Seo, Beung‐Chul Ahn, Kyoung‐Ho Pyo, Chun‐Bong Synn, Hong In Yoon, Hyo Sup Shim, Yong Il Lee et al. · 2020 · European Journal of Cancer
  23. TIGIT, A Novel Therapeutic Target for Tumor Immunotherapy
    Xinguang Liu, Ming Hou, Yu Liu · 2016 · Immunological Investigations
  24. Infiltration of T Cells into a Three-Dimensional Psoriatic Skin Model Mimics Pathological Key Features
    Isabelle Lorthois, Mélissa Simard, Sophie Morin, Roxane Pouliot · 2019 · International Journal of Molecular Sciences
  25. Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor
    Flavia Fontana, Manlio Fusciello, Christianne Groeneveldt, Cristian Capasso, Jacopo Chiaro, Sara Feola, Zehua Liu, Ermei M. Mäkilä, Jarno Salonen, Jouni J. Hirvonen et al. · 2019 · ACS Nano
  26. A versatile system to record cell-cell interactions
    Rui Tang, Christopher W. Murray, Ian L. Linde, Nicholas J. Kramer, Zhonglin Lyu, Min K. Tsai, Leo C. Chen, Hongchen Cai, Aaron D. Gitler, Edgar G. Engleman et al. · 2020 · eLife
  27. Extending the lifespan and efficacies of immune cells used in adoptive transfer for cancer immunotherapies–A review
    Sandeep Krishan Nayar, Prokar Dasgupta A, Christine Galustian · 2015 · OncoImmunology
  28. Naïve CD8+ T cell derived tumor-specific cytotoxic effectors as a potential remedy for overcoming TGF-β immunosuppression in the tumor microenvironment
    Hong Hanh Nguyen, Therasa Kim, Sang Yun Song, Somang Park, Hyang Hee Cho, Sung‐Hoon Jung, Jae‐Sook Ahn, Hyeoung‐Joon Kim, Je‐Jung Lee, Hee-Ok Kim et al. · 2016 · Scientific Reports
  29. PD-1/PD-L1 inhibitors in multiple myeloma: The present and the future
    Tomáš Jelı́nek, Roman Hájek · 2016 · OncoImmunology
  30. Single-cell transcriptome analysis reveals heterogeneity and convergence of the tumor microenvironment in colorectal cancer
    Siyuan Xie, Yangke Cai, Delong Chen, Yu Xiang, Wen Cai, Jianshan Mao, Jun Ye · 2023 · Frontiers in Immunology
  31. Disrupting B and T-cell collaboration in autoimmune disease: T-cell engagers versus CAR T-cell therapy?
    Kavina Shah, Maria José Leandro, Mark Steven Cragg, Florian Kollert, Franz Schuler, Christian Klein, Venkat R Reddy · 2024 · Clinical & Experimental Immunology
  32. T-Cell Senescence in Human Metabolic Diseases
    Ha Thi Nga, Thi Linh Nguyen, Hyon‐Seung Yi · 2024 · Diabetes & Metabolism Journal
  33. Polarization of macrophages towards M1 phenotype by a combination of 2-deoxy-d-glucose and radiation: Implications for tumor therapy
    Abdullah Farooque, Farhat Afrin, Jawahar Singh Adhikari, Bilikere Srinivasa Rao Dwarakanath · 2015 · Immunobiology
  34. Chemotherapy induces tumor immune evasion by upregulation of programmed cell death ligand 1 expression in bone marrow stromal cells
    Mengqi Yang, Panpan Liu, Kefeng Wang, Christophe Glorieux, Yumin Hu, Shijun Wen, Wenqi Jiang, Peng Huang · 2017 · Molecular Oncology
  35. Reversal of T Cell Exhaustion by the First Donor Lymphocyte Infusion Is Associated with the Persistently Effective Antileukemic Responses in Patients with Relapsed AML after Allo-HSCT
    Long Liu, Ying‐Jun Chang, Lan‐Ping Xu, Xiaohui Zhang, Yu Wang, Kai‐Yan Liu, Xiao-Jun Huang · 2018 · Transplantation and Cellular Therapy
  36. Revisiting T Cell Tolerance as a Checkpoint Target for Cancer Immunotherapy
    Simone Nüssing, Joseph A. Trapani, Ian A. Parish · 2020 · Frontiers in Immunology
  37. Reversing T-cell exhaustion in immunotherapy: a review on current approaches and limitations
    Yasser Tabana, Tae Chul Moon, Arno G. Siraki, Shokrollah Elahi, Khaled Barakat · 2021 · Expert Opinion on Therapeutic Targets
  38. Diacylglycerol kinases in T cell tolerance and effector function
    Chen, Shelley S., Hu, Zhiming, Zhong, Xiao-Ping · 2016 · Frontiers in Cell and Developmental Biology
  39. Reframing How Physical Activity Reduces The Incidence of Clinically-Diagnosed Cancers: Appraising Exercise-Induced Immuno-Modulation As An Integral Mechanism
    Annabelle Emery, Sally E. Moore, James E. Turner, John P. Campbell · 2022 · Frontiers in Oncology
  40. Exhausted T cells hijacking the cancer-immunity cycle: Assets and liabilities
    Anna E. Brunell, Riitta Lahesmaa, Anu K Autio, Anil K. Thotakura · 2023 · Frontiers in Immunology
  41. Cellular senescence in cancer: molecular mechanisms and therapeutic targets
    Ping Jin, Xirui Duan, Lei Li, Ping Zhou, Cheng‐Gang Zou, Ke Xie · 2024 · MedComm
  42. T-cell exhaustion in allograft rejection and tolerance
    Edward Benjamin Thorp, Christian Stehlik, Mohammed Javeed Ansari · 2015 · Current Opinion in Organ Transplantation
  43. Regulation of T cell immunity by cellular metabolism
    Zhilin Hu, Qiang Zou, Bing Su · 2018 · Frontiers of Medicine
  44. Immune Exhaustion: Past Lessons and New Insights from Lymphocytic Choriomeningitis Virus
    Shannon M. Kahan, Allan J Zajac · 2019 · Viruses
  45. Self and microbiota-derived epitopes induce CD4+ T cell anergy and conversion into CD4+Foxp3+ regulatory cells
    Michal Kuczma, Edyta A. Szurek, Anna Cebula, Vu L. Ngo, Maciej Pietrzak, Piotr Jan Kraj, Timothy Luke Denning, Leszek Ignatowicz · 2020 · Mucosal Immunology
  46. MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types
    Szu‐Yuan Wu, Kuan‐Chou Lin, Bashir Lawal, Alexander T.H. Wu, Ching‐Zong Wu · 2021 · Computational and Structural Biotechnology Journal
  47. Advances in CAR‐Engineered Immune Cell Generation: Engineering Approaches and Sourcing Strategies
    Zhaozhao Chen, Yu Hu, Heng Mei · 2023 · Advanced Science
  48. Cognate Nonlytic Interactions between CD8+ T Cells and Breast Cancer Cells Induce Cancer Stem Cell–like Properties
    Roland Gregor Stein, Stefan Ebert, Laura Schlahsa, Claus Jürgen Scholz, Matthias Braun, Petra Hauck, Evi Horn, Camelia‐Maria Monoranu, Vincent Thiemann, Michael P. Wustrow et al. · 2019 · Cancer Research
  49. Single-Cell RNA-Sequencing Shift in the Interaction Pattern Between Glioma Stem Cells and Immune Cells During Tumorigenesis
    You Zhai, Guanzhang Li, Renpeng Li, Yuanhao Chang, Yuemei Feng, Di Wang, Fan Wu, Wei Zhang · 2020 · Frontiers in Immunology
  50. Remodeling of Tumor Immune Microenvironment by Oncolytic Viruses
    Bin Zhang, Xilei Wang, Ping Cheng · 2021 · Frontiers in Oncology
  51. Single-cell RNA sequencing reveals XBP1-SLC38A2 axis as a metabolic regulator in cytotoxic T lymphocytes in multiple myeloma
    Yike Wan, Mengping Chen, Xin Li, Xiaofeng Han, Lu Zhong, Fei Xiao, Jia Liu, Jing Xiang, Jinxing Jiang, Xiaotong Chen et al. · 2023 · Cancer Letters
  52. A variety of ‘exhausted’ T cells in the tumor microenvironment
    Joji Nagasaki, Yosuke Togashi · 2022 · International Immunology
  53. Trispecific antibodies for cancer immunotherapy
    Yin Yao, Yiyin Hu, Fei Wang · 2023 · Immunology
  54. The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer—Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy
    Katarzyna Starska · 2023 · Cancers
  55. The recent progress of myeloid‐derived suppressor cell and its targeted therapies in cancers
    Ruiyang Ren, Chenyi Xiong, Runyu Ma, Yixuan Wang, Tianyang Yue, Jiayun Yu, Bin Shao · 2023 · MedComm
  56. The Different Functional Distribution of “Not Effector” T Cells (Treg/Tnull) in Colorectal Cancer
    Elena Niccolai, Federica Ricci, Edda Russo, Giulia Nannini, Giacomo Emmi, Antonio Taddei, Maria Novella Ringressi, Filippo Melli, Manouela Miloeva, Fabio Cianchi et al. · 2017 · Frontiers in Immunology
  57. The Role of Microbiota-Derived Vitamins in Immune Homeostasis and Enhancing Cancer Immunotherapy
    Hasti Gholami, John A. Chmiel, Jeremy P. Burton, Saman Maleki Vareki · 2023 · Cancers
  58. The Interplay between T Cells and Cancer: The Basis of Immunotherapy
    Christina Chen, Xin Liu, Che‐Yu Chang, Helen Y. Wang, Rong‐Fu Wang · 2023 · Genes
  59. Ewing Sarcoma Single-cell Transcriptome Analysis Reveals Functionally Impaired Antigen-presenting Cells
    Lindy L. Visser, Margit Bleijs, Thanasis Margaritis, Marc van de Wetering, Frank C. P. Holstege, Hans C. Clevers · 2023 · Cancer Research Communications
  60. Transcriptional response to hypoxic stress in melanoma and prognostic potential of GBE1 and BNIP3
    Stéphanie Buart, Stéphane Terry, Muhammad Zaeem Noman, Émilie Lanoy, C. Boutros, Paul Fogel, Philippe Dessen, Guillaume Meurice, Yann Gaston‐Mathé, Philippe R. Vielh et al. · 2017 · Oncotarget
  61. TIGIT expression is upregulated in T cells and causes T cell dysfunction independent of PD-1 and Tim-3 in adult B lineage acute lymphoblastic leukemia
    Xiaole Zhang, Hangfan Zhang, Lei Chen, Zhenjun Feng, Lei Gao, Qiang Li · 2019 · Cellular Immunology
  62. From Super-Enhancer Non-coding RNA to Immune Checkpoint: Frameworks to Functions
    Manqing Wu, Jun Shen · 2019 · Frontiers in Oncology
  63. Hydrogen gas activates coenzyme Q10 to restore exhausted CD8+ T cells, especially PD‑1+Tim3+terminal CD8+ T cells, leading to better nivolumab outcomes in patients with lung cancer
    Junji Akagi, Hideo Baba · 2020 · Oncology Letters
  64. Rho‐associated protein kinase‐dependent moesin phosphorylation is required for PD‐L1 stabilization in breast cancer
    Fanbiao Meng, Yang Su, Bo Xu · 2020 · Molecular Oncology
  65. Single cell multiomic analysis of T cell exhaustion in vitro
    Mirko Corselli, Suraj Saksena, Margaret A. Nakamoto, Woodrow E. Lomas, Ian Taylor, Pratip K. Chattopadhyay · 2021 · Cytometry Part A
  66. CD4 T cell dysfunction is associated with bacterial recrudescence during chronic tuberculosis
    Evelyn Chang, Kelly Cavallo, Samuel M. Behar · 2025 · Nature Communications
  67. Combined adjuvants of poly(I:C) plus LAG ‐3‐Ig improve antitumor effects of tumor‐specific T cells, preventing their exhaustion
    Yosuke Kano, Takahiro Iguchi, Hiroto Matsui, Keishi Adachi, Yukimi Sakoda, Tomoya Miyakawa, Shun Doi, Shoichi Hazama, Hiroaki Nagano, Yoshiya Ueyama et al. · 2016 · Cancer Science
  68. Molecular Imaging for Cancer Immunotherapy: Seeing Is Believing
    Madiha Saeed, Zhiai Xu, Bruno G. De Geest, Huixiong Xu, Haijun Yu · 2020 · Bioconjugate Chemistry
  69. Role of Exosomes in Immune Microenvironment of Hepatocellular Carcinoma
    Xiaojing Chen, Hao Chi, Xiaozhao Zhao, Rui Pan, Ying Wei, Yunwei Han · 2022 · Journal of Oncology
  70. Interleukin-12 family cytokines and sarcoidosis
    Sabine Ringkowski, Paul S. Thomas, Cristan A. Herbert · 2014 · Frontiers in Pharmacology
  71. T cell senescence: a new perspective on immunotherapy in lung cancer
    Mengge Huang, Yuetong Wang, Liguang Fang, Cun Liu, Fubin Feng, Lijuan Liu, Changgang Sun · 2024 · Frontiers in Immunology
  72. Overcoming resistance to PD-1 and CTLA-4 blockade mechanisms and therapeutic strategies
    Xiaodong Wang, Jing Na He, Gouping Ding, Yixuan Tang, Qianqian Wang · 2025 · Frontiers in Immunology
  73. New Strategies in Engineering T-cell Receptor Gene-Modified T cells to More Effectively Target Malignancies
    Thomas M. Schmitt, Ingunn M. Stromnes, Aude G. Chapuis, Philip D. Greenberg · 2015 · Clinical Cancer Research
  74. Modeling the Tumor Microenvironment and Pathogenic Signaling in Bone Sarcoma
    Eric R. Molina, Letitia K. Chim, Sergio Barrios, Joseph Aloysius Ludwig, Antonios G. Mikos · 2020 · Tissue Engineering Part B Reviews
  75. Excessive Costimulation Leads to Dysfunction of Adoptively Transferred T Cells
    Dinali Wijewarnasuriya, Christina Bebernitz, Andrea V. Lopez, Sarwish Rafiq, Renier J. Brentjens · 2020 · Cancer Immunology Research
  76. Targeting T Cell Activation in Immuno-Oncology
    Samuel David Saibil, Pamela S. Ohashi · 2020 · Current Oncology
  77. Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications
    Mariona Cabo, Rienk Offringa, Laurence Zitvogel, Guido Kroemer, Aura Muntasell, Lorenzo Galluzzi · 2017 · OncoImmunology
  78. CXCL3: A key player in tumor microenvironment and inflammatory diseases
    Yuxuan Bao, Chang Tong, Xiangyang Xiong · 2024 · Life Sciences
  79. Organoids Provide an Important Window on Inflammation in Cancer
    Kristi Baker · 2018 · Cancers
  80. A long way to the battlefront: CAR T cell therapy against solid cancers
    Zhicai Wang, Wei Chen, Xing Zhang, Zhiming Cai, Weiren Huang · 2019 · Journal of Cancer
  81. Circular RNA and tumor microenvironment
    Huixin Song, Qiaofei Liu, Quan Liao · 2020 · Cancer Cell International
  82. The multifaceted mechanisms of malignant glioblastoma progression and clinical implications
    Rui Sun, Albert H. Kim · 2022 · Cancer and Metastasis Reviews
  83. Enhancing immunity during ageing by targeting interactions within the tissue environment
    Olivia V. Bracken, Roel P. H. De Maeyer, Arne N. Akbar · 2025 · Nature Reviews Drug Discovery
  84. Short-term culture with IL-2 is beneficial for potent memory chimeric antigen receptor T cell production
    Xuhua Zhang, Xiaodong Lv, Yongping Song · 2017 · Biochemical and Biophysical Research Communications
  85. Non-coding RNA derived from extracellular vesicles in cancer immune escape: Biological functions and potential clinical applications
    Mingyao Huang, Xueqiang Peng, Liang Yang, Shuo Yang, Xinyu Li, Shilei Tang, Bowen Li, Hongyuan Jin, Bo Wu, Jingang Liu et al. · 2020 · Cancer Letters
  86. The Interplay Between Epigenetic Regulation and CD8+ T Cell Differentiation/Exhaustion for T Cell Immunotherapy
    Wai‐Ki Wong, Bohan Yin, Ching Ying Katherine Lam, Yingying Huang, Jiaxiang Yan, Zhiwu Tan, Siu Hong Dexter Wong · 2022 · Frontiers in Cell and Developmental Biology
  87. TIGIT signaling and its influence on T cell metabolism and immune cell function in the tumor microenvironment
    Nouria Jantz-Naeem, Romy Loschinski, Katrin Borucki, Marisa Mitchell-Flack, Martin Böttcher, Burkhart L. Schraven, Dimitrios Mougiakakos, Sascha Kahlfuß · 2023 · Frontiers in Oncology
  88. Surveying the Metabolic and Dysfunctional Profiles of T Cells and NK Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
    Jessica Maya · 2023 · International Journal of Molecular Sciences
  89. Pathological Mobilization and Activities of Dendritic Cells in Tumor-Bearing Hosts: Challenges and Opportunities for Immunotherapy of Cancer
    Amelia J. Tesone, Nikolaos Svoronos, Michael J. Allegrezza, Jose Ramon Conejo-Garcia · 2013 · Frontiers in Immunology
  90. Programmed death ligand 1 is expressed in canine B cell lymphoma and downregulated by MEK inhibitors
    Senthil R. Kumar, Dae Young Kim, Carolyn J. Henry, Jeffrey N. Bryan, Katherine L. Robinson, Andrew Eaton · 2017 · Veterinary and Comparative Oncology
  91. T Cell Memory to Vaccination
    Stephen M. Todryk · 2018 · Vaccines
  92. Effects of cellular senescence on metabolic pathways in non-immune and immune cells
    Daniela Frasca, Yara Bou Saada, Denisse Garcia, Bertrand Friguet · 2020 · Mechanisms of Ageing and Development
  93. End-Stage Renal Disease-Related Accelerated Immune Senescence: Is Rejuvenation of the Immune System a Therapeutic Goal?
    Didier Ducloux, Mathieu Legendre, Jamal Bamoulid, Philippe Saas, Cécile Courivaud, Thomas Crépin · 2021 · Frontiers in Medicine
  94. Evidence of exhausted lymphocytes after the third anti-SARS-CoV-2 vaccine dose in cancer patients
    Javier David Benítez Fuentes, Kauzar Mohamed Mohamed, Alicia de Luna Aguilar, Carlos Jiménez García, Kissy Guevara‐Hoyer, Miguel Fernández‐Arquero, M Antonia Rodríguez de la Peña, Laura García-Bravo, Alejandro Francisco Jiménez Ortega, Paloma Flores Navarro et al. · 2022 · Frontiers in Oncology
  95. FACS single cell index sorting is highly reliable and determines immune phenotypes of clonally expanded T cells
    Livius Penter, Kerstin Dietze, Lars Bullinger, Jörg Westermann, Hans-Peter Rahn, Leo Hansmann · 2018 · European Journal of Immunology
  96. Emerging role of microbiota in immunomodulation and cancer immunotherapy
    Raghwendra Pratap Singh, Hilal Bashir, Rashmi Kumar · 2020 · Seminars in Cancer Biology
  97. Immunological modulation of the Th1/Th2 shift by ionizing radiation in tumors (Review)
    Jiali Li, Zihang Zeng, Qiuji Wu, Jiarui Chen, Xingyu Liu, Jian‐Guo Zhang, Yuan Luo, Wenjie Sun, Zhengrong Huang, Junhong Zhang et al. · 2021 · International Journal of Oncology
  98. Response to immune checkpoint blockade improved in pre-clinical model of breast cancer after bariatric surgery
    Laura M. Sipe, Mehdi Chaib, Emily B Korba, Heejoon Jo, Mary Camille Lovely, Brittany R. Counts, Ubaid A. Tanveer, Jeremiah Ray Holt, Jared C Clements, Neena A John et al. · 2022 · eLife
  99. Heterogeneity of Cholangiocarcinoma Immune Biology
    Francesca Vita, Irene Olaizola, Francesco Amato, Colin J. Rae, Sergi Marco, Jesús M. Bañales, Chiara Braconi · 2023 · Cells
  100. The Expression of Programmed Death-1 in Circulating CD4+and CD8+T Cells during Hepatitis B Virus Infection Progression and Its Correlation with Clinical Baseline Characteristics
    Ping Xu, Yongjing Chen, Hui Chen, Xiaoyan Zhu, Huafeng Song, Lijuan Cao, Xuefeng Wang · 2014 · Gut and Liver